Ronald Allen Louks - 10 Sep 2021 Form 4 Insider Report for NantHealth, Inc.

Role: Chief Operating Officer
Signature: /s/ Brandon Villery, as Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 10 Sep 2021
Net transactions value: -$23,994
Form type: 4
Filing time: 14 Sep 2021, 21:11:42 UTC
Previous filing: 13 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NHIQ	Common Stock	Options Exercise	$4,027	+7,320	+3.2%	$0.5501	233,177	10 Sep 2021	Direct
transaction	NHIQ	Common Stock	Sale	$15,042	-7,320	-3.1%	$2.05	225,857	10 Sep 2021	Direct	F1
transaction	NHIQ	Common Stock	Options Exercise	$5,061	+9,200	+4.1%	$0.5501	235,057	13 Sep 2021	Direct
transaction	NHIQ	Common Stock	Sale	$18,039	-9,200	-3.9%	$1.96	225,857	13 Sep 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NHIQ	Stock Option (right to buy)	Options Exercise	$0	-7,320	-1.4%	$0.000000	519,862	10 Sep 2021	Common Stock	7,320	$0.5501	Direct	F3
transaction	NHIQ	Stock Option (right to buy)	Options Exercise	$0	-9,200	-1.8%	$0.000000	510,662	13 Sep 2021	Common Stock	9,200	$0.5501	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the weighted average share price of an aggregate total of 7,320 shares sold in the price range of $1.98 to $2.29 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2	Represents the weighted average share price of an aggregate total of 9,200 shares sold in the price range of $1.96 to $1.97 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3	Subject to the reporting person continuing as a service provider, the shares subject to the option shall vest as follows, fifty percent (50%) of the shares subject to the option shall vest on the one (1) year anniversary from the date of grant, and twenty-five percent (25%) of the remaining shares subject to the option shall vest annually thereafter, so that the option is fully vested on the three (3) year anniversary date.